 | • レポートコード：QYR2104Z4045 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、壊死性筋膜炎治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アミノグリコシド系抗生物質、メトロニダゾール系抗生物質、クリンダマイシン系抗生物質、フルオロコナゾール系抗生物質、その他）、用途別市場規模（病院薬局、オンライン薬局、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・壊死性筋膜炎治療薬の市場動向 ・企業の競争状況、市場シェア ・壊死性筋膜炎治療薬の種類別市場規模（アミノグリコシド系抗生物質、メトロニダゾール系抗生物質、クリンダマイシン系抗生物質、フルオロコナゾール系抗生物質、その他） ・壊死性筋膜炎治療薬の用途別市場規模（病院薬局、オンライン薬局、ドラッグストア） ・壊死性筋膜炎治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・壊死性筋膜炎治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・壊死性筋膜炎治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・壊死性筋膜炎治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・壊死性筋膜炎治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Pfizer、Bristol-Myers Squibb、Merck、Abbott、Teva、WOCKHARDT、Atox Bio、Basilea Pharmaceutica、MELINTA THERAPEUTICS） ・結論 |
Necrotizing Fasciitis is rare but serious bacterial infection commonly known as flesh eating disease which affects the tissue beneath the skin and surrounding organs and muscles.
Market Analysis and Insights: Global Necrotizing Fasciitis Drug Market
The global Necrotizing Fasciitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Necrotizing Fasciitis Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Necrotizing Fasciitis Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Necrotizing Fasciitis Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Necrotizing Fasciitis Drug market.
Global Necrotizing Fasciitis Drug Scope and Market Size
Necrotizing Fasciitis Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Necrotizing Fasciitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Aminoglycoside
Metronidazole
Clindamycin
Fluoroconazoles
Others
Segment by Application
Hospital Pharmacies
Online Pharnacies
Retail Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline
Pfizer
Bristol-Myers Squibb
Merck
Abbott
Teva
WOCKHARDT
Atox Bio
Basilea Pharmaceutica
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Necrotizing Fasciitis Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Aminoglycoside
1.2.3 Metronidazole
1.2.4 Clindamycin
1.2.5 Fluoroconazoles
1.2.6 Others
1.3 Market by Application
1.3.1 Global Necrotizing Fasciitis Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Online Pharnacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Necrotizing Fasciitis Drug Market Perspective (2016-2027)
2.2 Necrotizing Fasciitis Drug Growth Trends by Regions
2.2.1 Necrotizing Fasciitis Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Necrotizing Fasciitis Drug Historic Market Share by Regions (2016-2021)
2.2.3 Necrotizing Fasciitis Drug Forecasted Market Size by Regions (2022-2027)
2.3 Necrotizing Fasciitis Drug Industry Dynamic
2.3.1 Necrotizing Fasciitis Drug Market Trends
2.3.2 Necrotizing Fasciitis Drug Market Drivers
2.3.3 Necrotizing Fasciitis Drug Market Challenges
2.3.4 Necrotizing Fasciitis Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Necrotizing Fasciitis Drug Players by Revenue
3.1.1 Global Top Necrotizing Fasciitis Drug Players by Revenue (2016-2021)
3.1.2 Global Necrotizing Fasciitis Drug Revenue Market Share by Players (2016-2021)
3.2 Global Necrotizing Fasciitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Necrotizing Fasciitis Drug Revenue
3.4 Global Necrotizing Fasciitis Drug Market Concentration Ratio
3.4.1 Global Necrotizing Fasciitis Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Necrotizing Fasciitis Drug Revenue in 2020
3.5 Necrotizing Fasciitis Drug Key Players Head office and Area Served
3.6 Key Players Necrotizing Fasciitis Drug Product Solution and Service
3.7 Date of Enter into Necrotizing Fasciitis Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Necrotizing Fasciitis Drug Breakdown Data by Type
4.1 Global Necrotizing Fasciitis Drug Historic Market Size by Type (2016-2021)
4.2 Global Necrotizing Fasciitis Drug Forecasted Market Size by Type (2022-2027)
5 Necrotizing Fasciitis Drug Breakdown Data by Application
5.1 Global Necrotizing Fasciitis Drug Historic Market Size by Application (2016-2021)
5.2 Global Necrotizing Fasciitis Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Necrotizing Fasciitis Drug Market Size (2016-2027)
6.2 North America Necrotizing Fasciitis Drug Market Size by Type
6.2.1 North America Necrotizing Fasciitis Drug Market Size by Type (2016-2021)
6.2.2 North America Necrotizing Fasciitis Drug Market Size by Type (2022-2027)
6.2.3 North America Necrotizing Fasciitis Drug Market Size by Type (2016-2027)
6.3 North America Necrotizing Fasciitis Drug Market Size by Application
6.3.1 North America Necrotizing Fasciitis Drug Market Size by Application (2016-2021)
6.3.2 North America Necrotizing Fasciitis Drug Market Size by Application (2022-2027)
6.3.3 North America Necrotizing Fasciitis Drug Market Size by Application (2016-2027)
6.4 North America Necrotizing Fasciitis Drug Market Size by Country
6.4.1 North America Necrotizing Fasciitis Drug Market Size by Country (2016-2021)
6.4.2 North America Necrotizing Fasciitis Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Necrotizing Fasciitis Drug Market Size (2016-2027)
7.2 Europe Necrotizing Fasciitis Drug Market Size by Type
7.2.1 Europe Necrotizing Fasciitis Drug Market Size by Type (2016-2021)
7.2.2 Europe Necrotizing Fasciitis Drug Market Size by Type (2022-2027)
7.2.3 Europe Necrotizing Fasciitis Drug Market Size by Type (2016-2027)
7.3 Europe Necrotizing Fasciitis Drug Market Size by Application
7.3.1 Europe Necrotizing Fasciitis Drug Market Size by Application (2016-2021)
7.3.2 Europe Necrotizing Fasciitis Drug Market Size by Application (2022-2027)
7.3.3 Europe Necrotizing Fasciitis Drug Market Size by Application (2016-2027)
7.4 Europe Necrotizing Fasciitis Drug Market Size by Country
7.4.1 Europe Necrotizing Fasciitis Drug Market Size by Country (2016-2021)
7.4.2 Europe Necrotizing Fasciitis Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Necrotizing Fasciitis Drug Market Size (2016-2027)
8.2 Asia-Pacific Necrotizing Fasciitis Drug Market Size by Type
8.2.1 Asia-Pacific Necrotizing Fasciitis Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Necrotizing Fasciitis Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Necrotizing Fasciitis Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Necrotizing Fasciitis Drug Market Size by Application
8.3.1 Asia-Pacific Necrotizing Fasciitis Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Necrotizing Fasciitis Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Necrotizing Fasciitis Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Necrotizing Fasciitis Drug Market Size by Region
8.4.1 Asia-Pacific Necrotizing Fasciitis Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Necrotizing Fasciitis Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Necrotizing Fasciitis Drug Market Size (2016-2027)
9.2 Latin America Necrotizing Fasciitis Drug Market Size by Type
9.2.1 Latin America Necrotizing Fasciitis Drug Market Size by Type (2016-2021)
9.2.2 Latin America Necrotizing Fasciitis Drug Market Size by Type (2022-2027)
9.2.3 Latin America Necrotizing Fasciitis Drug Market Size by Type (2016-2027)
9.3 Latin America Necrotizing Fasciitis Drug Market Size by Application
9.3.1 Latin America Necrotizing Fasciitis Drug Market Size by Application (2016-2021)
9.3.2 Latin America Necrotizing Fasciitis Drug Market Size by Application (2022-2027)
9.3.3 Latin America Necrotizing Fasciitis Drug Market Size by Application (2016-2027)
9.4 Latin America Necrotizing Fasciitis Drug Market Size by Country
9.4.1 Latin America Necrotizing Fasciitis Drug Market Size by Country (2016-2021)
9.4.2 Latin America Necrotizing Fasciitis Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Necrotizing Fasciitis Drug Market Size (2016-2027)
10.2 Middle East & Africa Necrotizing Fasciitis Drug Market Size by Type
10.2.1 Middle East & Africa Necrotizing Fasciitis Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Necrotizing Fasciitis Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Necrotizing Fasciitis Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Necrotizing Fasciitis Drug Market Size by Application
10.3.1 Middle East & Africa Necrotizing Fasciitis Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Necrotizing Fasciitis Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Necrotizing Fasciitis Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Necrotizing Fasciitis Drug Market Size by Country
10.4.1 Middle East & Africa Necrotizing Fasciitis Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Necrotizing Fasciitis Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Necrotizing Fasciitis Drug Introduction
11.1.4 GlaxoSmithKline Revenue in Necrotizing Fasciitis Drug Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Necrotizing Fasciitis Drug Introduction
11.2.4 Pfizer Revenue in Necrotizing Fasciitis Drug Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Necrotizing Fasciitis Drug Introduction
11.3.4 Bristol-Myers Squibb Revenue in Necrotizing Fasciitis Drug Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Necrotizing Fasciitis Drug Introduction
11.4.4 Merck Revenue in Necrotizing Fasciitis Drug Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Necrotizing Fasciitis Drug Introduction
11.5.4 Abbott Revenue in Necrotizing Fasciitis Drug Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Necrotizing Fasciitis Drug Introduction
11.6.4 Teva Revenue in Necrotizing Fasciitis Drug Business (2016-2021)
11.6.5 Teva Recent Development
11.7 WOCKHARDT
11.7.1 WOCKHARDT Company Details
11.7.2 WOCKHARDT Business Overview
11.7.3 WOCKHARDT Necrotizing Fasciitis Drug Introduction
11.7.4 WOCKHARDT Revenue in Necrotizing Fasciitis Drug Business (2016-2021)
11.7.5 WOCKHARDT Recent Development
11.8 Atox Bio
11.8.1 Atox Bio Company Details
11.8.2 Atox Bio Business Overview
11.8.3 Atox Bio Necrotizing Fasciitis Drug Introduction
11.8.4 Atox Bio Revenue in Necrotizing Fasciitis Drug Business (2016-2021)
11.8.5 Atox Bio Recent Development
11.9 Basilea Pharmaceutica
11.9.1 Basilea Pharmaceutica Company Details
11.9.2 Basilea Pharmaceutica Business Overview
11.9.3 Basilea Pharmaceutica Necrotizing Fasciitis Drug Introduction
11.9.4 Basilea Pharmaceutica Revenue in Necrotizing Fasciitis Drug Business (2016-2021)
11.9.5 Basilea Pharmaceutica Recent Development
11.10 MELINTA THERAPEUTICS
11.10.1 MELINTA THERAPEUTICS Company Details
11.10.2 MELINTA THERAPEUTICS Business Overview
11.10.3 MELINTA THERAPEUTICS Necrotizing Fasciitis Drug Introduction
11.10.4 MELINTA THERAPEUTICS Revenue in Necrotizing Fasciitis Drug Business (2016-2021)
11.10.5 MELINTA THERAPEUTICS Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Necrotizing Fasciitis Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Aminoglycoside
Table 3. Key Players of Metronidazole
Table 4. Key Players of Clindamycin
Table 5. Key Players of Fluoroconazoles
Table 6. Key Players of Others
Table 7. Global Necrotizing Fasciitis Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Necrotizing Fasciitis Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Necrotizing Fasciitis Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Necrotizing Fasciitis Drug Market Share by Regions (2016-2021)
Table 11. Global Necrotizing Fasciitis Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Necrotizing Fasciitis Drug Market Share by Regions (2022-2027)
Table 13. Necrotizing Fasciitis Drug Market Trends
Table 14. Necrotizing Fasciitis Drug Market Drivers
Table 15. Necrotizing Fasciitis Drug Market Challenges
Table 16. Necrotizing Fasciitis Drug Market Restraints
Table 17. Global Necrotizing Fasciitis Drug Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Necrotizing Fasciitis Drug Market Share by Players (2016-2021)
Table 19. Global Top Necrotizing Fasciitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotizing Fasciitis Drug as of 2020)
Table 20. Ranking of Global Top Necrotizing Fasciitis Drug Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Necrotizing Fasciitis Drug Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Necrotizing Fasciitis Drug Product Solution and Service
Table 24. Date of Enter into Necrotizing Fasciitis Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Necrotizing Fasciitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Necrotizing Fasciitis Drug Revenue Market Share by Type (2016-2021)
Table 28. Global Necrotizing Fasciitis Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Necrotizing Fasciitis Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Necrotizing Fasciitis Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Necrotizing Fasciitis Drug Revenue Market Share by Application (2016-2021)
Table 32. Global Necrotizing Fasciitis Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Necrotizing Fasciitis Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Necrotizing Fasciitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Necrotizing Fasciitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Necrotizing Fasciitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Necrotizing Fasciitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Necrotizing Fasciitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Necrotizing Fasciitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Necrotizing Fasciitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Necrotizing Fasciitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Necrotizing Fasciitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Necrotizing Fasciitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Necrotizing Fasciitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Necrotizing Fasciitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Necrotizing Fasciitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Necrotizing Fasciitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Necrotizing Fasciitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Necrotizing Fasciitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Necrotizing Fasciitis Drug Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Necrotizing Fasciitis Drug Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Necrotizing Fasciitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Necrotizing Fasciitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Necrotizing Fasciitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Necrotizing Fasciitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Necrotizing Fasciitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Necrotizing Fasciitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Necrotizing Fasciitis Drug Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Necrotizing Fasciitis Drug Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Necrotizing Fasciitis Drug Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Necrotizing Fasciitis Drug Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Necrotizing Fasciitis Drug Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Necrotizing Fasciitis Drug Market Size by Country (2022-2027) & (US$ Million)
Table 64. GlaxoSmithKline Company Details
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Necrotizing Fasciitis Drug Product
Table 67. GlaxoSmithKline Revenue in Necrotizing Fasciitis Drug Business (2016-2021) & (US$ Million)
Table 68. GlaxoSmithKline Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Necrotizing Fasciitis Drug Product
Table 72. Pfizer Revenue in Necrotizing Fasciitis Drug Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Bristol-Myers Squibb Company Details
Table 75. Bristol-Myers Squibb Business Overview
Table 76. Bristol-Myers Squibb Necrotizing Fasciitis Drug Product
Table 77. Bristol-Myers Squibb Revenue in Necrotizing Fasciitis Drug Business (2016-2021) & (US$ Million)
Table 78. Bristol-Myers Squibb Recent Development
Table 79. Merck Company Details
Table 80. Merck Business Overview
Table 81. Merck Necrotizing Fasciitis Drug Product
Table 82. Merck Revenue in Necrotizing Fasciitis Drug Business (2016-2021) & (US$ Million)
Table 83. Merck Recent Development
Table 84. Abbott Company Details
Table 85. Abbott Business Overview
Table 86. Abbott Necrotizing Fasciitis Drug Product
Table 87. Abbott Revenue in Necrotizing Fasciitis Drug Business (2016-2021) & (US$ Million)
Table 88. Abbott Recent Development
Table 89. Teva Company Details
Table 90. Teva Business Overview
Table 91. Teva Necrotizing Fasciitis Drug Product
Table 92. Teva Revenue in Necrotizing Fasciitis Drug Business (2016-2021) & (US$ Million)
Table 93. Teva Recent Development
Table 94. WOCKHARDT Company Details
Table 95. WOCKHARDT Business Overview
Table 96. WOCKHARDT Necrotizing Fasciitis Drug Product
Table 97. WOCKHARDT Revenue in Necrotizing Fasciitis Drug Business (2016-2021) & (US$ Million)
Table 98. WOCKHARDT Recent Development
Table 99. Atox Bio Company Details
Table 100. Atox Bio Business Overview
Table 101. Atox Bio Revenue in Necrotizing Fasciitis Drug Business (2016-2021) & (US$ Million)
Table 102. Atox Bio Recent Development
Table 103. Basilea Pharmaceutica Company Details
Table 104. Basilea Pharmaceutica Business Overview
Table 105. Basilea Pharmaceutica Necrotizing Fasciitis Drug Product
Table 106. Basilea Pharmaceutica Revenue in Necrotizing Fasciitis Drug Business (2016-2021) & (US$ Million)
Table 107. Basilea Pharmaceutica Recent Development
Table 108. MELINTA THERAPEUTICS Company Details
Table 109. MELINTA THERAPEUTICS Business Overview
Table 110. MELINTA THERAPEUTICS Necrotizing Fasciitis Drug Product
Table 111. MELINTA THERAPEUTICS Revenue in Necrotizing Fasciitis Drug Business (2016-2021) & (US$ Million)
Table 112. MELINTA THERAPEUTICS Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Necrotizing Fasciitis Drug Market Share by Type: 2020 VS 2027
Figure 2. Aminoglycoside Features
Figure 3. Metronidazole Features
Figure 4. Clindamycin Features
Figure 5. Fluoroconazoles Features
Figure 6. Others Features
Figure 7. Global Necrotizing Fasciitis Drug Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Online Pharnacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Necrotizing Fasciitis Drug Report Years Considered
Figure 12. Global Necrotizing Fasciitis Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Necrotizing Fasciitis Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Necrotizing Fasciitis Drug Market Share by Regions: 2020 VS 2027
Figure 15. Global Necrotizing Fasciitis Drug Market Share by Regions (2022-2027)
Figure 16. Global Necrotizing Fasciitis Drug Market Share by Players in 2020
Figure 17. Global Top Necrotizing Fasciitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotizing Fasciitis Drug as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Necrotizing Fasciitis Drug Revenue in 2020
Figure 19. Global Necrotizing Fasciitis Drug Revenue Market Share by Type (2016-2021)
Figure 20. Global Necrotizing Fasciitis Drug Revenue Market Share by Type (2022-2027)
Figure 21. North America Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Necrotizing Fasciitis Drug Market Share by Type (2016-2027)
Figure 23. North America Necrotizing Fasciitis Drug Market Share by Application (2016-2027)
Figure 24. North America Necrotizing Fasciitis Drug Market Share by Country (2016-2027)
Figure 25. United States Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Necrotizing Fasciitis Drug Market Share by Type (2016-2027)
Figure 29. Europe Necrotizing Fasciitis Drug Market Share by Application (2016-2027)
Figure 30. Europe Necrotizing Fasciitis Drug Market Share by Country (2016-2027)
Figure 31. Germany Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Necrotizing Fasciitis Drug Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Necrotizing Fasciitis Drug Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Necrotizing Fasciitis Drug Market Share by Region (2016-2027)
Figure 41. China Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Necrotizing Fasciitis Drug Market Share by Type (2016-2027)
Figure 49. Latin America Necrotizing Fasciitis Drug Market Share by Application (2016-2027)
Figure 50. Latin America Necrotizing Fasciitis Drug Market Share by Country (2016-2027)
Figure 51. Mexico Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Necrotizing Fasciitis Drug Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Necrotizing Fasciitis Drug Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Necrotizing Fasciitis Drug Market Share by Country (2016-2027)
Figure 57. Turkey Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Necrotizing Fasciitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Necrotizing Fasciitis Drug Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Necrotizing Fasciitis Drug Business (2016-2021)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Necrotizing Fasciitis Drug Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Necrotizing Fasciitis Drug Business (2016-2021)
Figure 64. Abbott Revenue Growth Rate in Necrotizing Fasciitis Drug Business (2016-2021)
Figure 65. Teva Revenue Growth Rate in Necrotizing Fasciitis Drug Business (2016-2021)
Figure 66. WOCKHARDT Revenue Growth Rate in Necrotizing Fasciitis Drug Business (2016-2021)
Figure 67. Atox Bio Revenue Growth Rate in Necrotizing Fasciitis Drug Business (2016-2021)
Figure 68. Basilea Pharmaceutica Revenue Growth Rate in Necrotizing Fasciitis Drug Business (2016-2021)
Figure 69. MELINTA THERAPEUTICS Revenue Growth Rate in Necrotizing Fasciitis Drug Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の壊死性皮膚感染症治療市場規模・現状・予測（2021年-2027年） Necrotizing skin infections ranks among the most rarely found diseases but are highly lethal infection. Necrotizing skin infection arise primarily in any layer of skin soft tissue such as dermis and epidermis that are associated with necrotizing changes. Necrotizing skin infection is also commonly c…- 世界の心臓代謝薬市場規模・現状・予測（2021年-2027年） Cardiometabolic drugs are purposefully used for a vast composition of metabolic dysfunction, disorders include impaired glucose tolerance, insulin resistance, hypertension, dyslipidemia, and central adiposity. Market Analysis and Insights: Global Cardiometabolic Drug Market The global Cardiometaboli…
- 世界の心臓代謝薬市場規模・現状・予測（2021年-2027年） Cardiometabolic drugs are purposefully used for a vast composition of metabolic dysfunction, disorders include impaired glucose tolerance, insulin resistance, hypertension, dyslipidemia, and central adiposity. Market Analysis and Insights: Global Cardiometabolic Drug Market The global Cardiometaboli…
- 世界の小売薬市場規模・現状・予測（2021年-2027年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…
- 世界の過眠症治療薬市場規模・現状・予測（2021年-2027年） Hypersomnia indicates frequent and excessive daytime sleepiness. It becomes necessary for patients suffering from hypersomnia to take short naps in-between the day time and sleep more than 10 hours at night. However, the naps do not provide any relief. Also, patients may feel disoriented and can hav…